FCF Yield

The current FCF Yield of -39.2% means Editas Medicine is generating negative free cash flow (money left after operating and capital expenses) relative to its market value—for every $100 of equity, the company burns about $39 in cash.

This is far worse than the healthcare sector median of 3.5%, and the stock ranks in the 2nd percentile among sector peers, indicating nearly all competitors have higher (more positive) yields. The year-over-year change is not available (N/A), but the quarter-over-quarter change shows a +57.0% improvement, meaning the negative yield narrowed from -91.2% in the prior quarter to -39.2% now. A deeply negative FCF Yield combined with a recent sharp improvement suggests high cash-burn risk is moderating, but the level remains extreme. This metric strongly supports the overall CAUTIOUS verdict, as negative cash flow at this magnitude signals continued reliance on external funding and limited financial flexibility.

Frequently Asked Questions

Closest Sector Peers